← Back
$BBNX All transactions

Beta Bionics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$18K

Shares

600

Price

$30

Filed

Jan 5

Insider

Name

Mensinger Mike

Title

Chief Product Officer

CIK

0002048500

Roles

Officer

Transaction Details

Transaction Date

2026-01-02

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

82,952

Footnotes

Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on September 8, 2025. | The weighted average sale price for the transaction reported was $29.56 and the range of prices were between $29.05 and $30.02. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. | The weighted average sale price for the transaction reported was $30.1969 and the range of prices were between $30.10 and $30.52. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

Filing Info

Accession No.

0002048500-26-000002

Form Type

4

Issuer CIK

0001674632

Mensinger Mike's History

Date Ticker Type Value
2026-03-02 BBNX $13K
2026-02-27 BBNX A $0
2026-02-27 BBNX A $0
2026-02-27 BBNX A $0
2026-01-06 BBNX $66K
2026-01-02 BBNX $213K
2026-01-02 BBNX $18K
2025-12-02 BBNX $31K
2025-09-02 BBNX $21K
2025-06-02 BBNX $5K

Other Insiders at BBNX (90d)

Insider Bought Sold Last
Hopman Mark
Chief Commercial Officer
$103K 2026-03-04
Mensinger Mike
Chief Product Officer
$13K 2026-03-02
Feider Stephen
Chief Financial Officer
$18K 2026-03-02
Saint Sean
President & CEO
$42K 2026-03-02
Russell Steven Jon
Chief Medical Officer
$43K 2026-03-02